CC chemokine receptor 4-positive diffuse large B-cell lymphoma involving the skin: A case report

International Journal of Hematology

Volumn 82, Issue 2, 2005, Pages 148-151

  Ishida, Takashi ^a,b   Inagaki, Hiroshi ^a   Kusumoto, Shigeru ^b   Inagaki, Atsushi ^a   Komatsu, Hirokazu ^a   Iida, Shinsuke ^a   Harada, Shinsuke ^b   Takeuchi, Genji ^b   Ueda, Ryuzo ^a  

^a NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

^b SHIZUOKA SAISEIKAI GENERAL HOSPITAL   (Japan)

Author keywords

CCR4; Diffuse large B cell lymphoma; TARC

Indexed keywords

CHEMOKINE RECEPTOR CCR4; CYCLOPHOSPHAMIDE; DOXORUBICIN; PREDNISOLONE; THYMUS AND ACTIVATION REGULATED CHEMOKINE; VINCRISTINE;

ADULT; ARTICLE; AXILLA; B CELL LYMPHOMA; CANCER RADIOTHERAPY; CASE REPORT; CLINICAL EXAMINATION; DIFFUSE LARGE B CELL LYMPHOMA; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LARGE CELL LYMPHOMA; MALE; PATHOGENESIS; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKIN; SKIN LYMPHOMA; SKIN ULCER; STOMACH LYMPHOMA;

CHEMOKINES, CC; FACIAL NEOPLASMS; HUMANS; LYMPHOMA, B-CELL; LYMPHOMA, LARGE-CELL, DIFFUSE; MALE; MIDDLE AGED; RECEPTORS, CHEMOKINE; SKIN NEOPLASMS;

EID: 24144457516     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1532/IJH97.04154     Document Type: Article

References (16)

1. Zlotnik A, Yoshie O. Chemokines: a new classification system and their role in immunity. Immunity. 2000;12:121-127.
2. Campbell JJ, Butcher EC. Chemokines in tissue-specific and microenvironment-specific lymphocyte homing. Curr Opin Immunol. 2000;12:336-341.
3. Bucher EC, Williams M, Youngman K, Rott L, Briskin M. Lymphocyte trafficking and regional immunity. Adv Immunol. 1999;72: 209-253.
4. Müller A, Homey B, Soto H, et al. Involvement of chemokine receptors in breast cancer metastasis. Nature. 2001;410:50-56.
5. Kunkel EJ, Boisvert J, Murphy K, et al. Expression of the chemokine receptors CCR4, CCR5, and CXCR3 by human tissue-infiltrating lymphocytes. Am J Pathol. 2002;160:347-355.
6. Campbell JJ, Haraldsen G, Pan JR, et al. The chemokine receptor CCR4 in vascular recognition by cutaneous but not intestinal memory T cells. Nature. 1999;400:776-780.
7. Imai T, Baba M, Nishimura M, Kakizaki M, Takagi S, Yoshie O. The T cell-directed CC chemokine TARC is a highly specific biological ligand for CC chemokine receptor 4. J Biol Chem. 1997;272: 15036-15042.
8. Ishida T, Utsunomiya A, Iida S, et al. Clinical significance of CCR4 expression in adult T-cell leukemia/lymphoma (ATLL): its close association with skin involvement and unfavorable outcome. Clin Cancer Res. 2003;9:3625-3634.
9. Yoshie O, Fujisawa R, Nakayama T, et al. Frequent expression of CCR4 in adult T-cell leukemia and human T-cell leukemia virus type 1-transformed T cells. Blood. 2002;99:1505-1511.
10. Ishida T, Inagaki H, Utsunomiya A, et al. CXCR3 and CCR4 expression in T-cell and NK-cell lymphomas with special reference to clinicopathological significance for peripheral T-cell lymphoma, unspecified. Clin Cancer Res. 2004;10:5494-5500.
11. Ishida T, Iida S, Akatsuka Y, et al. The CC chemokine receptor 4 (CCR4) as a novel specific molecular target for immunotherapy in adult T-cell leukemia/lymphoma. Clin Cancer Res. 2004;10: 7529-7539.
12. Girardi M, Heald PW, Wilson LD. The pathogenesis of mycosis fungoides. N Engl J Med. 2004;350:1978-1988.
13. Imai T, Nagira M, Takagi S, et al. Selective recruitment of CCR4-bearing Th2 cells toward antigen-presenting cells by the CC chemokines thymus and activation-regulated chemokine and macrophage-derived chemokine. Int Immunol. 1999;11:81-88.
14. Marti RM, Campo E, Bosch F, Palou J, Estrach T. Cutaneous lymphocyte-associated antigen (CLA) expression in a lymphoblastoid mantle cell lymphoma presenting with skin lesions: comparison with other clinicopathologic presentations of mantle cell lymphoma. J. Cutan Pathol. 2001;28:256-264.
15. Gatter KC, Warnke RA. Diffuse large B-cell lymphoma. In: Jaffe ES, Harris NL, Stem H, Vardiman JW, eds. WHO Classification of Tumours: Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. Lyon, France: IARC Press; 2001:171-174.
16. Niwa R, Shoji-Hosaka E, Sakurada M, et al. Defucosylated chimeric anti-CCR4 IgG1 with enhanced antibody-dependent cellular cytotoxicity shows potent therapeutic activity to T cell leukemia and lymphoma. Cancer Res. 2004;64:2127-2133.